The above chart presents the market trend analysis for altadis farmaceutica s.a.s. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 5 transactions, with a transaction quantity of 13519 and a transaction weight of 13519.
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO 1070543808-0001. PEDIDO TRAMITE: 3160 (2¿). DECLARACION(1-1). NOS ACOGEMOS A LA LEY 1669 DE JULIO 16 DE 2013, DECRETO 1636 DEL 31 DE JULIO DE 2013, DECRETO 1513 DEL 18 DE JULIO DE 2013, MEMORANDO 000286 DEL 30 DE JULIO DE 2013. DECRETO NUMERO 2247 DE 2014, MINISTERIO DE COMERCIO, INDUSTRIA Y TURISMO; CIRCULAR NUMERO 22 DE 2013. AUTORIZACION ADUANERA NO. A048/H/001/2014). PRODUCTO: MEDICAMENTO. NOMBRE COMERCIAL: PRAZENTOL 1MG/ML. PRINCIPIO ACTIVO: ARIPIPRAZOL. CONCENTRACION: 1 MG. INDICACIONES TERAPEUTICAS: ARIPIPRAZOL ESTA INDICADO EN EL TRATAMIENTO DE LOS EPISODIOS MANOACOS O MIXTOS EN EL TRASTORNO BIPOLAR I (EN ADULTOS Y NIÑOS DE 10 AÑOS EN ADELANTE), COMO MONOTERAPIA O COADYUVANTE CON LITIO O VALPROATO. EN EL MANTENIMIENTO COMO MONOTERAPIA O TERAPIAADYUVANTE AL TRATAMIENTO CON LITIO O VALPROATO EN EL TRASTORNO BIPOLAR I. ARIPIPRAZOL TAMBIEN ESTA INDICADO EN EL TRATAMIENTO DE LA AGITACION PSICOMOTRIZ E IRRITABILIDAD EN EL TRASTORNO AUTISTA EN NIÑOS MAYORES DE 6 AÑOS Y ADOLESCENTES HASTA LOS 17 AÑOS.FORM
Expand
3smb technologies
belgiumbuyer,they trade on 2025-12-09
144.29%
>
4zeillock inc.
othersupplier,they trade on 2025-12-24
41.23%
>
5atlantic pharma
united statesbuyer,they trade on 2025-08-12
30.92%
>
+View All
Products
Total 8
ProductsTransactionsPerDetail
equipped with fixed dose drug 7865.55%>
madic 2218.49%>
pharm 1512.61%>
buprenorphine 21.68%>
ethylmorphine 21.68%>
+View All
Hscode rank
Total 7
HSCode NameTransactionsPerDetail
HS 30049029007865.55%>
HS 293911600021.68%>
HS 293379900010.84%>
HS 293499900010.84%>
Trading Area
Total 7
AreaTransactionsPerDetail
portugal16951.84%>
costa rica8726.69%>
other3811.66%>
belgium103.07%>
hungary51.53%>
+View All
Port statistics
Total 3
Port NameTransactionsPerDetail
bogota4313.19%>
port everglades, fl3711.35%>
especial de cartagena164.91%>
altadis farmaceutica s.a.s. is colombia Buyer&Supplier,
and primarily engages in the import and export business of products such as equipped with fixed dose drug,madic,pharm.
According to the 52wmb.com global trade database, as of 2026-01-16, the company has completed 330 international trades,
with its main trading regions covering portugal,costa rica,other etc.
The core products include HS3004902900,HS2939116000,HS2933799000 etc,
often transported via bogota,port port everglades, fl, port especial de cartagena etc,
and its main trading partners are tecnimede sociedade tecnico medicinal s.a.,tecnimede soc.tecnico medicinal s,smb technologies.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on altadis farmaceutica s.a.s. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.